This is a Double-blind, Placebo-controlled, Randomized Study of the Tolerability, Safety and Immunogenicity of an Inactivated Whole Virion Concentrated Purified Vaccine (CoviVac) Against Covid-19
Clinical trial NCT05046548 · COMPLETED
Trial details
- NCT number
- NCT05046548
- Sponsor
- Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-03
- Primary completion
- 2020-10-15
- Enrollment
- 400
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.